Turk Dermatoloji Dergisi-Turkish Journal of Dermatology, published by Wolters Kluwer Medknow Publications, is a prominent platform dedicated to advancing the field of dermatology in Turkey and beyond. With an ISSN of 1307-7635 and an E-ISSN of 1308-5255, this journal plays a vital role in disseminating contemporary research and clinical advancements within the domain. While it is positioned in the Q4 quartile of dermatology journals, its contributions are essential for academics, medical practitioners, and students averse to the latest trends and breakthroughs in skin health. The journal assures accessibility to a broad audience, fostering knowledge exchange, collaboration, and innovation. Given its unique perspective rooted in Turkish dermatological practices, the Turkish Journal of Dermatology serves as a significant resource for enhancing professional competence and driving forward the science of dermatology through its vivid discussions and case studies. For researchers seeking a dedicated venue to publish their work or for professionals eager to stay informed, this journal is an indispensable resource in the ever-evolving landscape of dermatology.

The American Journal of Clinical Dermatology, published by Adis International Ltd, is a leading peer-reviewed journal dedicated to advancing the field of dermatology. With a notable impact factor and a prestigious Q1 rank in both Dermatology and Miscellaneous Medicine categories, this journal stands out as a valuable resource for researchers and clinicians alike, offering cutting-edge insights into clinical practice and innovative treatment strategies. Its comprehensive scope encompasses a broad range of topics within dermatology, addressing both common and rare conditions, with a focus on emerging therapies and technologies. As it converges its publication years from 2000 to 2024, the journal remains an essential platform for disseminating high-quality research to professionals striving to improve patient care and outcomes. With the ISSN 1175-0561 and E-ISSN 1179-1888, the American Journal of Clinical Dermatology facilitates greater accessibility to pivotal findings within the field, making it an indispensable resource for anyone involved in dermatological research and practice.

The Hong Kong Journal of Dermatology & Venereology is a vital publication in the field of dermatology, dedicated to advancing research and clinical practice in this specialized area. Published by MEDCOM LTD, this journal has been a resourceful platform for dermatologists, researchers, and students since its inception in 2005, showcasing rigorous original research, comprehensive reviews, and case studies pertinent to both dermatology and venereology. Although currently categorized in Q4 of the dermatology quartiles, it serves as an important voice for the region, contributing to the global dialogue on skin and sexually transmitted diseases. With an ISSN of 1814-7453, the journal aims to bridge gaps in understanding and foster innovations that will lead to better patient care and outcomes. Readers can access its content, while researchers are encouraged to contribute to this growing body of knowledge that plays a critical role in enhancing dermatological practice in Hong Kong and beyond.

Dermatology Research and Practice is a premier open access journal published by HINDAWI LTD, dedicated to advancing the field of dermatology since its establishment in 2009. With a respectable impact factor and a ranking of #42 out of 142 in the Scopus Medicine - Dermatology category, the journal stands in the 70th percentile, reflecting its influence and relevance in contemporary dermatological research. Based in Egypt, it provides a platform for groundbreaking studies that shape clinical practice and policy worldwide. The journal covers a wide range of topics within dermatology, including but not limited to clinical research, epidemiology, and patient care, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding and contribute to the field. Emphasizing open access, Dermatology Research and Practice ensures that vital research findings are readily available to the global community, fostering collaboration and innovation in dermatology.

Journal of Dermatology & Dermatologic Surgery (JDDS) is a premier open access journal published by Wolters Kluwer Medknow Publications since 2018. This journal serves as a vital platform for the dissemination of cutting-edge research and advancements in the field of dermatology and dermatologic surgery. With its ISSN 2352-2410 and E-ISSN 2352-2429, JDDS strives to present high-quality articles that encompass clinical studies, innovative surgical techniques, and comprehensive reviews, thereby catering to the interests of researchers, medical professionals, and students alike. The journal has gained recognition within the academic community, evidenced by its Scopus ranks, placing it 237th out of 551 in the Medicine - Surgery category and 70th out of 142 in Medicine - Dermatology. The open access model not only enhances visibility but also encourages global collaboration and knowledge sharing in the rapidly evolving field of dermatology. Targeting the needs of diverse audiences, JDDS continues to foster an environment for scholarly communication and contributes significantly to the advancement of dermatologic sciences.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, published by Mosby-Elsevier, stands at the forefront of dermatological research and education. With an impressive impact factor and categorized as Q1 in Dermatology, this journal has established itself as a pivotal resource for healthcare professionals and researchers in the field. Since its inception in 1979, it has provided a platform for high-quality peer-reviewed articles, contributing significantly to advancements in dermatological science and practice through 2024. The journal commands an honorable position, ranking #8 out of 142 in the Scopus database's medicine dermatology category, placing it in the 94th percentile among its peers. Readers can access a wealth of cutting-edge studies, case reports, and reviews that address a broad spectrum of topics, from clinical dermatology to emerging therapies. In addition, the journal's commitment to excellence ensures it remains an essential tool for students, clinicians, and researchers dedicated to improving skin health and furthering knowledge in dermatology.

The Journal of Cutaneous Immunology and Allergy, published by FRONTIERS MEDIA SA in Switzerland, is an esteemed Open Access platform dedicated to advancing research in the intersecting fields of dermatology, immunology, and allergy. Since its inception in 2018, this journal has provided a vital resource for the dissemination of innovative research findings and critical reviews, enhancing our understanding of cutaneous conditions related to immune responses. Although currently classified in the Q4 quartile in both Dermatology and Immunology & Allergy categories as of 2023, the journal continues to strive for recognition within the scientific community, encouraging collaboration and knowledge sharing among researchers, clinicians, and experts. The journal boasts an E-ISSN of 2574-4593 and is committed to making high-quality research freely accessible to all, thus fostering greater insights into the complexities of skin-related immune disorders. Join us in this journey to explore the forefront of cutaneous research and contribute to the evolving dialogue in this dynamic field.

Journal of Drugs in Dermatology, an esteemed publication in the field of dermatology, serves as a vital resource for researchers, clinicians, and healthcare professionals dedicated to advancing knowledge and practices in skin-related therapies and treatments. Established in 2002 and published in the United States, this journal focuses on a wide range of topics pertinent to dermatological pharmacology and therapeutics, reflecting contemporary scientific advancements and innovative approaches to patient care. With a strong presence in Scopus rankings, situating it at rank #73 within the dermatology category, and achieving a commendable Q2 quartile classification in both dermatology and general medicine categories, the journal is committed to enhancing understanding of drug efficacy and safety in dermatological conditions. While the journal maintains a traditional access model, its impact factor underscores its significance in the research community, supporting the ongoing dialogue between academia and clinical practice. We invite professionals and students alike to explore the latest findings and contribute to the progressive discourse on dermatological treatments through this important publication.

CLINICAL AND EXPERIMENTAL DERMATOLOGY is a prominent journal in the field of dermatology, published by Oxford University Press. With an ISSN of 0307-6938 and an E-ISSN of 1365-2230, this journal has been a vital resource for researchers and practitioners since its inception in 1976. Recognized as a Q2 journal within the category of dermatology for 2023, it holds a respectable position, ranking #54 among 142 journals in this discipline, placing it in the 62nd percentile on Scopus. The journal is dedicated to publishing high-quality research that spans clinical and experimental aspects of dermatological science, making it an essential source of knowledge for advancing understanding and treatment of skin disorders. Although it operates on a traditional subscription model without open access options, its contributions to the field are significant, influencing both clinical practices and academic research. Researchers, clinicians, and students alike will find vital insights and contemporary themes presented in its pages, supporting ongoing education and innovation in dermatology.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, published by Wiley, is a premier peer-reviewed journal dedicated to advancing the fields of dermatology and venereology. Since its inception in 1991, this esteemed journal has established itself as a vital resource, providing a platform for innovative research and critical analysis in these important medical disciplines. With an impressive Impact Factor stemming from its Q1 category ranks in both dermatology and infectious diseases, it has achieved a dominant position, ranking #4 out of 142 in Dermatology and #37 out of 344 in Infectious Diseases according to Scopus. Researchers and clinicians alike are encouraged to engage with the rich content and robust discussions presented in its pages, fostering collaboration and cutting-edge advancements in patient care. Access options to this journal can be explored through Wiley, allowing for widespread dissemination and engagement in the academic community. The journal’s ongoing commitment to excellence ensures its relevance and significance in shaping the future of dermatological and venereological research.